SI1830835T1 - Uporaba agonista vaniloidnega receptorja skupaj zglikozaminoglikanom ali proteoglikanom za proizvodnjo agensa za zdravljenje bolečin v sklepih in metoda in apliciranje omenjenega agensa - Google Patents

Uporaba agonista vaniloidnega receptorja skupaj zglikozaminoglikanom ali proteoglikanom za proizvodnjo agensa za zdravljenje bolečin v sklepih in metoda in apliciranje omenjenega agensa

Info

Publication number
SI1830835T1
SI1830835T1 SI200431886T SI200431886T SI1830835T1 SI 1830835 T1 SI1830835 T1 SI 1830835T1 SI 200431886 T SI200431886 T SI 200431886T SI 200431886 T SI200431886 T SI 200431886T SI 1830835 T1 SI1830835 T1 SI 1830835T1
Authority
SI
Slovenia
Prior art keywords
agent
glycosaminoglycan
producing
receptor agonist
proteoglycan
Prior art date
Application number
SI200431886T
Other languages
English (en)
Inventor
Dominik Meyer
Original Assignee
Mestex Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mestex Ag filed Critical Mestex Ag
Publication of SI1830835T1 publication Critical patent/SI1830835T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SI200431886T 2004-12-28 2004-12-28 Uporaba agonista vaniloidnega receptorja skupaj zglikozaminoglikanom ali proteoglikanom za proizvodnjo agensa za zdravljenje bolečin v sklepih in metoda in apliciranje omenjenega agensa SI1830835T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04802397A EP1830835B1 (de) 2004-12-28 2004-12-28 Verwendung eines vanilloidrezeptoragonisten zusammen mit einem glycosaminoglycan oder proteoglycan f]r die herstellung eines mittels zur behandlung von gelenkschmerzen und verfahren zur applikation dieses mittels
PCT/CH2004/000757 WO2006069452A1 (de) 2004-12-28 2004-12-28 Verwendung eines vanilloidrezeptoragonisten zusammen mit einem glycosaminoglycan oder proteoglycan für die herstellung eines mittels zur behandlung von gelenkschmerzen und verfahren zur applikation dieses mittels

Publications (1)

Publication Number Publication Date
SI1830835T1 true SI1830835T1 (sl) 2012-07-31

Family

ID=34959550

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431886T SI1830835T1 (sl) 2004-12-28 2004-12-28 Uporaba agonista vaniloidnega receptorja skupaj zglikozaminoglikanom ali proteoglikanom za proizvodnjo agensa za zdravljenje bolečin v sklepih in metoda in apliciranje omenjenega agensa

Country Status (11)

Country Link
US (1) US8703741B2 (sl)
EP (1) EP1830835B1 (sl)
JP (1) JP5080983B2 (sl)
AT (1) ATE549018T1 (sl)
CA (1) CA2594203C (sl)
DK (1) DK1830835T3 (sl)
ES (1) ES2384244T3 (sl)
PL (1) PL1830835T3 (sl)
PT (1) PT1830835E (sl)
SI (1) SI1830835T1 (sl)
WO (1) WO2006069452A1 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100076037A1 (en) 2006-11-02 2010-03-25 Chiang Lillian W Methods of Treating Neuropathic Pain with Agonists of PPAR-gamma
US8870876B2 (en) 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
CN105101949A (zh) 2012-11-12 2015-11-25 Api起源有限责任公司 水基辣椒素类物质制剂及其制备方法和应用
PT3732994T (pt) 2013-02-08 2022-12-02 Gen Mills Inc Produtos alimentares com reduzido teor de sódio
EP2818162A1 (en) * 2013-06-28 2014-12-31 Encubator AB A composition for use in the treatment of intervertebral disc-related pain
US20150133561A1 (en) 2013-11-12 2015-05-14 Vizuri Health Sciences Llc Aqueous based capsaicinoid formulations and methods of manufacture and use
WO2015160941A1 (en) * 2014-04-15 2015-10-22 Vizuri Health Sciences Llc Topical compositions for pain relief, manufacture and use
CA3041121A1 (en) 2016-11-02 2018-05-11 Centrexion Therapeutics Corporation Stable aqueous capsaicin injectable formulations and medical uses thereof
EP3654961A4 (en) 2017-07-20 2021-04-21 Centrexion Therapeutics Corporation METHODS AND COMPOSITIONS FOR TREATMENT OF PAIN WITH CAPSAICIN
AU2018327301A1 (en) * 2017-09-11 2020-04-09 Vivasor, Inc. Formulation of resiniferatoxin
US11254659B1 (en) 2019-01-18 2022-02-22 Centrexion Therapeutics Corporation Capsaicinoid prodrug compounds and their use in treating medical conditions
US11447444B1 (en) 2019-01-18 2022-09-20 Centrexion Therapeutics Corporation Capsaicinoid prodrug compounds and their use in treating medical conditions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8501723L (sv) * 1985-04-09 1986-10-10 Pharmacia Ab Preparation att anvendas vid behandling av ledinflammation
DE69806246T3 (de) * 1997-03-13 2006-05-18 Campbell, James N. Zusammensetzung enthaltend capsaicin oder seine analogen und lokalanästhetika
WO2003099013A1 (en) * 2000-01-24 2003-12-04 Omni Nutraceuticals, Inc. Acetaminophen/non-steroidal anti-inflamatory drug-glucosamine composition
US6689399B1 (en) * 2000-03-16 2004-02-10 James R. Dickson Transdermal delivery of an anti-inflammatory composition
US20030104085A1 (en) * 2001-12-05 2003-06-05 Yeomans David C. Methods and compositions for treating back pain
MXPA05006670A (es) * 2002-12-18 2005-10-19 Algorx Pharmaceuticals Inc Administracion de capsaicinoides.
US20040186182A1 (en) * 2002-12-18 2004-09-23 Algorx Administration of capsaicinoids
US20040254142A1 (en) * 2003-06-12 2004-12-16 Robert Kovler Arthritic and joint condition formulation
US20050232980A1 (en) * 2004-04-15 2005-10-20 Chen Andrew L Transdermal chondroitin and glucosamine delivery system and method of use
ATE489086T1 (de) 2004-12-22 2010-12-15 Mestex Ag Mischung eines vanilloidrezeptoragonisten mit einer nervenregenerationshemmenden substanz, ihre verwendung für die herstellung eines schmerzmittels und verfahren zur applikation dieses mittels

Also Published As

Publication number Publication date
JP5080983B2 (ja) 2012-11-21
US20080153780A1 (en) 2008-06-26
US8703741B2 (en) 2014-04-22
ES2384244T3 (es) 2012-07-02
EP1830835B1 (de) 2012-03-14
WO2006069452A1 (de) 2006-07-06
ATE549018T1 (de) 2012-03-15
DK1830835T3 (da) 2012-07-02
EP1830835A1 (de) 2007-09-12
CA2594203C (en) 2014-04-29
PL1830835T3 (pl) 2012-08-31
JP2008525505A (ja) 2008-07-17
PT1830835E (pt) 2012-06-25
CA2594203A1 (en) 2006-07-06

Similar Documents

Publication Publication Date Title
SI1830835T1 (sl) Uporaba agonista vaniloidnega receptorja skupaj zglikozaminoglikanom ali proteoglikanom za proizvodnjo agensa za zdravljenje bolečin v sklepih in metoda in apliciranje omenjenega agensa
EP1861161A4 (en) APPARATUS AND METHOD FOR DISPENSING THERAPEUTIC AND / OR OTHER AGENTS IN THE INTERNAL EAR AND OTHER FABRICS
HK1210977A1 (en) Humanized anti-beta7 antagonists and uses therefor -7
ZA200500323B (en) Use of lkb kinase inhibitors for the treatment of pain.
WO2005102338A8 (en) Method of treating neuropathic pain using a crth2 receptor antagonist
EP1991315A4 (en) APPLICATOR FOR THE TREATMENT OF THE SKIN AND THIS USE METHOD FOR THE TREATMENT OF THE SKIN
GB2455695B (en) Apparatus and method for the reduction of pain using vibration, cold and distractive elements
EP2068999A4 (en) IMPLANTABLE DEVICE AND METHOD FOR THE TREATMENT OF STERILE CURVES AND OTHER DISEASES
TW200630096A (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
RS20120498A1 (en) PROCEDURE FOR THE TREATMENT OF ATHEROSCLEROSIS, DISLIPIDEMIA AND ASSOCIATED CONDITIONS AND PHARMACEUTICAL COMPOSITION
PL1809742T3 (pl) Sposoby leczenia stawów związanych z gromadzeniem nadmiaru macierzy pozakomórkowej
WO2004084943A8 (en) Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation
PT2054045E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento da artrite e da dor
UA88655C2 (ru) S-миртазапин для лечения прилива крови
MX2009011744A (es) Formulaciones de dosis unitaria y metodos para tratar y prevenir trombosis con antagonistas del receptor de tromboxano.
WO2008079727A3 (en) Compositions comprising an pan-alpha-2 receptor agonist and an anticonvulsant for treating chronic pain
MX2007007206A (es) Uso de un agonista 5-ht6 para el tratamiento y la prevencion de trastornos neurodegenerativos.
EP1898950A4 (en) GALK1S MODIFIERS OF THE PTEN / AKT PATHWAY AND METHODS OF USE
HK1141436A1 (en) Axomadol for treating pain from arthritis
WO2008089494A3 (en) Methods of use of epsilon inhibitor compounds for the attenuation of pain
TW200730150A (en) Methods for determining coating thickness of a prosthesis
TW200603802A (en) Method of treating neuropathic pain
EP1660114A4 (en) METHOD AND COMPOSITIONS FOR TREATING DYSFUNCTIONS OF THE EXTRACELLULAR MATRIX
TW200733948A (en) Massage method and apparatus